Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.79 |
| ▸ | CA6 | P23280 | 5/20 | 0.79 |
| ▸ | CA7 | P43166 | 5/20 | 0.79 |
| ▸ | CA9 | Q16790 | 5/20 | 0.79 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.79 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.79 |
| ▸ | CA2 | P00918 | 4/20 | 0.79 |
| ▸ | CA4 | P22748 | 4/20 | 0.79 |
| ▸ | CA5A | P35218 | 4/20 | 0.79 |
| ▸ | CA3 | P07451 | 3/20 | 0.79 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | RECQL | P46063 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.73 |
| ▸ | F13A1 | P00488 | 2/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.73 |
| ▸ | THPO | P40225 | 2/20 | 0.73 |
| ▸ | CASP2 | P42575 | 2/20 | 0.73 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6658738 | 1.00 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7712115 | 1.00 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL11808474 | 0.96 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| Hydrochloric Acid SCHEMBL6250226 | 0.96 | UBE2N (0.75) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9720429 | 0.96 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL26667 | 0.96 | CA12 (0.85) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18784646 | 0.93 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18700922 | 0.93 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL817205 | 0.93 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7206015 | 0.93 | CA12 (0.81) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372871-B1 | CURABLE LIQUID MIXTURE OF A POLYMER, PREFERABLY ACRYLIC, HAVING A 1,3-OXATHIOLANE-2-THIOL AND A KETIMINE, ENAMINE OR AN ALDIMINE; COATINGS; ADHESIVES; INKS; SEALS; STORAGE STABILITY | KYOWA YUKA CO., LTD. (JP) | 2002-04-16 | — | — | US | claimed |
| EP-0943660-A1 | DITHIOCARBONATE COMPOSITION | Kyowa Yuka Co., Ltd. (JP) | 1999-09-22 | — | — | EP | claimed |
| EP-0512423-B1 | Aqueous solutions of cationic polyamidoamine resins | HOECHST AG (DE) | 1998-07-22 | — | — | EP | claimed |
| WO-2026102259-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | MOSAIC MATERIALS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260131275-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | MOSAIC MAT INC (US) | 2026-05-14 | — | — | US | disclosed |
| CN-119463844-A | High-efficiency gelatinizing agent for acidification and preparation method thereof | 四川盛年同缔实业有限公司 | 2025-02-18 | — | — | CN | disclosed |
| EP-1490359-B1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MED & SCIENCE INC (US) | 2010-05-19 | — | — | EP | disclosed |
| US-6979681-B2 | Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer | UNIVERSITY COURT, THE UNIVERSITY OF EDINBURGH (GB) | 2005-12-27 | — | — | US | disclosed |
| US-20050239765-A1 | Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer | UNIVERSITY COURT, THE UNIVERSITY OF EDINBURGH, A UNITED KINGDOM CORPORATION | 2005-10-27 | — | — | US | disclosed |
| EP-1224192-B1 | HALF-SANDWICH RUTHENIUM (II) COMPOUNDS COMPRISING NITROGEN CONTAINING LIGANDS FOR TREATMENT OF CANCER | UNIV COURT THE UNIVERSITY OF E (GB) | 2005-08-31 | — | — | EP | disclosed |
| US-6936634-B2 | Ruthenium (II) compounds for use in the therapy of cancer | THE UNIVERSITY COURT, THE UNIVERSITY OF EDINBURGH (UK) (GB) | 2005-08-30 | — | — | US | disclosed |
| EP-0396824-A1 | Process for the production of a multicolour liquid crystal display device | AGFA-GEVAERT N.V. (BE) | 1990-11-14 | — | — | EP | disclosed |
| EP-0351456-A1 | Process for the preparation of a laminate | AGFA-GEVAERT N.V. (BE) | 1990-01-24 | — | — | EP | disclosed |
| US-4689374-A | Water soluble polyamidoaminepolyamine having weight average molecular weight of at least 5×105 | W. R. GRACE & CO. (US) | 1987-08-25 | — | — | US | disclosed |
| EP-0031899-B1 | SELF-CROSSLINKING WATER-SOLUBLE REACTION PRODUCTS, PROCESS FOR PRODUCING BINDING AGENTS FROM SUCH PRODUCTS, AND USE OF THE PRODUCTS TO INCREASE THE WET STRENGTH OF PAPER | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-06-06 | — | — | EP | disclosed |
| EP-0042940-B1 | HETEROALKYLENE-BIS-ANTHRAQUINONES | AMERICAN CYANAMID COMPANY (US) | 1984-06-06 | — | — | EP | disclosed |
| EP-0042940-A1 | Heteroalkylene-bis-anthraquinones | AMERICAN CYANAMID COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| EP-0031899-A1 | Self-crosslinking water-soluble reaction products, process for producing binding agents from such products, and use of the products to increase the wet strength of paper | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-07-15 | — | — | EP | disclosed |
| US-4278605-A | ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-07-14 | — | — | US | disclosed |
| US-4163754-A | Fluorinated sulfonamides | ICI AMERICAS INC. (US) | 1979-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050239765-A1 | Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer | NR0B1, NR0B2, NCOR1 | CA12 2859/4885CA6 2165/4885CA7 389/4885 |
| US-20260131275-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | EXOSC9, EXOSC4, EXOSC5 | CA12 1281/4885CA6 2138/4885CA7 1795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.